2 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 2 |
Follow IGM-6268: new trials by email Literature Review of IGM-6268 trials Research Report on IGM-6268
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of IGM-6268 in Healthy Adults and Patients With Mild to Moderate COVID-19 IGM-6268, Placebo - Healthy Volunteers, COVID-19 | Phase 1 | Terminated | IGM Biosciences, Inc. | 26 | 2022-01-20 | 2022-10-14 |
| Evaluation of IGM-6268 in Healthy Volunteers IGM-6268, Placebo - Healthy Volunteers | Phase 1 | Terminated | IGM Biosciences, Inc. | 54 | 2021-12-07 | 2022-10-14 |
COVID-19 (1)
South Africa (1) · United States (1)
Roel Funke (2)